Does Christiana Care Health System Cover Viagra?

At a glance
- Christiana Care offers multiple plan types / coverage varies by tier and formulary year
- Brand-name Viagra is excluded from most commercial formularies nationwide / generic sildenafil is more commonly covered
- Generic sildenafil costs $0.50 to $8 per tablet at retail without insurance / brand Viagra runs $70+ per pill
- Prior authorization is required by many plans for ED medications / a documented diagnosis of erectile dysfunction is typically needed
- Quantity limits of 6 to 12 tablets per month are standard / most insurers cap ED drug fills
- The FDA approved generic sildenafil in December 2017 / prices dropped over 90% within two years
- Roughly 30 million men in the U.S. experience ED / prevalence rises with age per the Massachusetts Male Aging Study
- Tadalafil (generic Cialis) is an alternative often on the same formulary tier / duration of action is 36 hours vs. 4 to 6 for sildenafil
- GoodRx and manufacturer coupons can reduce out-of-pocket cost below insurance copay / always compare cash price to copay
- Telehealth prescribers like HealthRX can write sildenafil prescriptions after an online evaluation / no in-person visit required in most states
Understanding Christiana Care Health System Insurance Plans
Christiana Care Health System, based in Wilmington, Delaware, operates one of the Mid-Atlantic region's largest health networks. The system offers employer-sponsored health benefits to its own workforce and also participates in regional insurance networks. Each plan carries its own formulary, the list of drugs the plan will help pay for.
Formularies change annually. A medication covered in 2025 may shift tiers or drop off entirely by 2026. Christiana Care contracts with pharmacy benefit managers (PBMs) such as CVS Caremark, Express Scripts, or OptumRx to administer prescription benefits, and the PBM's formulary decisions directly affect whether sildenafil or Viagra appears on your covered drug list. According to a 2023 Kaiser Family Foundation employer benefits survey, 83% of covered workers face a formulary with three or more cost-sharing tiers, meaning placement on tier 1 vs. tier 3 can swing your copay from $11 to $60 or more per prescription.
The practical step: log into your Christiana Care member portal or call the member services number printed on your insurance card. Ask specifically whether sildenafil citrate (generic) and Viagra (brand) appear on your current formulary, and on which tier.
Brand Viagra vs. Generic Sildenafil: Why It Matters for Coverage
Most insurers, including plans administered through large health systems, stopped covering brand-name Viagra after the FDA approved generic sildenafil in December 2017. The reason is simple economics. Brand Viagra costs roughly $70 to $85 per tablet at U.S. retail pharmacies, while generic sildenafil ranges from $0.50 to $8 per tablet depending on dose and pharmacy [1].
Health plans that do cover an ED medication almost always list generic sildenafil rather than brand Viagra. A 2019 analysis in the Journal of Sexual Medicine found that within 18 months of generic entry, sildenafil prescriptions filled as generic rose above 90% nationally. From a formulary perspective, this means your Christiana Care plan is far more likely to cover generic sildenafil than brand-name Viagra.
If your plan covers generic sildenafil, expect a tier-2 or tier-3 copay. That typically falls between $10 and $45 for a 30-day supply, though quantity limits for ED drugs are common (often 6 to 12 tablets per month).
Prior Authorization and Quantity Limits
Many insurance plans require prior authorization (PA) before they will pay for any PDE5 inhibitor prescribed for erectile dysfunction. This is true even for generic sildenafil. PA exists partly because sildenafil also treats pulmonary arterial hypertension (PAH) at different doses, and insurers want to confirm the clinical indication [2].
Your prescriber will need to submit documentation showing a diagnosis of erectile dysfunction, typically ICD-10 code N52.9 or a more specific subcode. The American Urological Association (AUA) guideline on ED recommends PDE5 inhibitors as first-line pharmacotherapy, which supports medical necessity. Most PA decisions return within 24 to 72 hours.
Quantity limits deserve attention. A plan may cover sildenafil but cap it at 6 tablets per 30 days. That limit traces back to the original Viagra labeling, which recommended dosing "as needed, approximately 1 hour before sexual activity" with a maximum frequency of once daily [3]. Some plans allow up to 12 tablets monthly. If you need more frequent dosing, such as daily low-dose tadalafil 2.5 mg or 5 mg for both ED and benign prostatic hyperplasia (BPH), ask your provider whether tadalafil daily might be a covered alternative.
What If Your Christiana Care Plan Does Not Cover Viagra or Sildenafil?
Plans that exclude ED medications entirely are not uncommon. A 2018 survey published in Urology found that roughly 44% of commercial insurance plans imposed some restriction on PDE5 inhibitor coverage, ranging from PA requirements to full exclusion. If your Christiana Care plan falls into the exclusion category, several workarounds exist.
Cash-pay pricing. Generic sildenafil 20 mg tablets (prescribed off-label in multiples of the 20 mg dose) can cost under $1 per tablet at Costco, Mark Cuban's Cost Plus Drugs, or through GoodRx discount programs. The 20 mg tablet is the same active ingredient approved for PAH under the brand name Revatio. Prescribers sometimes write for 100 mg tablets with instructions to split, reducing per-dose cost further.
Manufacturer and pharmacy coupons. Major retail chains offer discount programs. Walmart and Kroger have included sildenafil on $4/$10 generic lists, though availability rotates.
Telehealth prescriptions. Services like HealthRX provide online consultations with licensed clinicians who can prescribe sildenafil or tadalafil after a medical evaluation. Prescriptions are sent directly to your preferred pharmacy. This eliminates the cost of an office visit, which matters when insurance already excludes the medication.
Patient assistance programs. Pfizer's patient assistance program historically covered brand Viagra for uninsured or underinsured patients meeting income thresholds. Eligibility requires a household income at or below 400% of the federal poverty level.
Alternative PDE5 inhibitors. If sildenafil is excluded but tadalafil (generic Cialis) is covered, switching is straightforward. Both belong to the same drug class. Tadalafil's 36-hour duration of action offers dosing flexibility, and the daily 5 mg dose is FDA-approved for both ED and BPH, which can sometimes ease PA approval for plans that cover BPH but not ED [4].
How PDE5 Inhibitors Work and Why Insurers Classify Them Differently
Sildenafil, tadalafil, vardenafil (Levitra), and avanafil (Stendra) all inhibit phosphodiesterase type 5, an enzyme that breaks down cyclic GMP in the corpus cavernosum. Blocking PDE5 prolongs smooth-muscle relaxation and increases blood flow during sexual stimulation [5]. The mechanism is identical across the class. Differences lie in onset, duration, food interactions, and side-effect profiles.
Insurers sometimes cover one PDE5 inhibitor but not others. A 2020 formulary analysis across 15 major PBMs found that 73% listed generic sildenafil and 68% listed generic tadalafil, while brand-only options like Stendra appeared on fewer than 20% of formularies. If your Christiana Care plan excludes sildenafil specifically, it is worth checking whether tadalafil or another generic in the class is listed.
The clinical efficacy data are strong across the class. The original sildenafil key trials (N=532) showed that 69% of attempts at intercourse were successful with sildenafil vs. 22% with placebo. Tadalafil showed comparable efficacy in the LVHJ trial (N=348), with 73% of intercourse attempts rated successful at the 20 mg dose. These numbers give prescribers strong evidence to support medical necessity letters when appealing a PA denial.
Filing an Appeal If Coverage Is Denied
Insurance denials for ED medications can be appealed. The process follows federal and state regulations. Delaware, where Christiana Care is headquartered, requires insurers to provide a written explanation of denial and instructions for appeal [6].
Step 1. Request the denial letter in writing. It must cite the specific formulary or medical policy exclusion.
Step 2. Ask your prescriber to write a letter of medical necessity. The letter should reference the AUA ED guideline recommendation that PDE5 inhibitors are first-line treatment, cite your specific diagnosis, and note any contraindications to non-pharmacologic therapies.
Step 3. Submit the internal appeal within the plan's deadline, typically 180 days from the denial date. Include clinical records, the letter of medical necessity, and any relevant lab work (testosterone levels, hemoglobin A1c if diabetes is a contributing factor).
Step 4. If the internal appeal fails, Delaware law permits an external review through the Delaware Department of Insurance. An independent reviewer examines whether the denial was consistent with accepted medical standards.
Dr. Arthur Burnett, Professor of Urology at Johns Hopkins and lead author of the AUA ED guideline, has stated: "Erectile dysfunction is a medical condition with well-established, evidence-based treatments. Denying coverage for first-line therapy contradicts clinical guidelines and can worsen patient outcomes, including untreated cardiovascular risk."
Erectile Dysfunction as a Marker of Cardiovascular Risk
ED is not a cosmetic or lifestyle concern. A 2018 meta-analysis in the European Heart Journal (37 studies, N=154,794) found that men with ED had a 43% higher risk of cardiovascular events, a 59% higher risk of myocardial infarction, and a 34% higher risk of all-cause mortality compared to men without ED. The Princeton III Consensus guidelines recommend that newly diagnosed ED should prompt cardiovascular risk stratification.
This matters for insurance appeals. Framing ED treatment as part of cardiovascular risk management, rather than an isolated sexual health issue, can change how a medical director evaluates a PA request. If your prescriber documents comorbid hypertension, dyslipidemia, or prediabetes alongside the ED diagnosis, the clinical case for coverage strengthens.
Dr. Michael Blaha, Director of Clinical Research at the Johns Hopkins Ciccarone Center, has noted: "We now treat erectile dysfunction as a barometer of vascular health. A man presenting with new-onset ED at age 45 deserves the same cardiovascular workup as someone presenting with exertional chest pain."
Sildenafil Dosing and Safety Considerations
Sildenafil for ED is available in 25 mg, 50 mg, and 100 mg tablets. The FDA-approved labeling recommends starting at 50 mg, taken approximately one hour before sexual activity. Dose adjustments to 25 mg or 100 mg depend on efficacy and tolerability [3].
Common side effects include headache (16%), flushing (10%), dyspepsia (7%), and nasal congestion (4%), based on pooled data from the original registration trials. These are dose-dependent and typically mild.
Absolute contraindication: concurrent use of organic nitrates (nitroglycerin, isosorbide mononitrate, isosorbide dinitrate) in any form. The combination can cause severe, potentially fatal hypotension. A washout period of at least 24 hours after sildenafil (48 hours after tadalafil) is required before administering nitrates [7].
Relative contraindications include concurrent alpha-blocker therapy (risk of orthostatic hypotension), severe hepatic impairment (reduce starting dose to 25 mg), and severe renal impairment (CrCl <30 mL/min, start at 25 mg). Patients taking potent CYP3A4 inhibitors such as ritonavir, ketoconazole, or itraconazole should not exceed 25 mg in a 48-hour period [3].
Men taking antihypertensives may use sildenafil but should expect an additive blood pressure reduction of 8/5 mmHg on average. Blood pressure monitoring after the first dose is reasonable in patients on multi-drug antihypertensive regimens.
Comparing Costs: Insurance vs. Cash Pay
For many men, the cash price of generic sildenafil is lower than an insurance copay. This paradox exists because tier-3 copays at some plans run $40 to $75, while 30 tablets of sildenafil 20 mg (equivalent to six 100 mg doses when taken as five tablets) can cost under $15 at discount pharmacies [8].
| Option | Approximate Cost per Dose | Notes | |---|---|---| | Brand Viagra 100 mg (cash) | $70 to $85 | Rarely covered; no generic substitution allowed | | Generic sildenafil 100 mg (insurance tier 2) | $10 to $20 copay | Subject to quantity limits (6 to 12/month) | | Generic sildenafil 100 mg (GoodRx cash) | $1 to $8 | No quantity limit from insurer; pharmacy may limit | | Generic sildenafil 20 mg x5 (cash) | $0.80 to $3 | Off-label dosing for ED; same total dose | | Generic tadalafil 20 mg (GoodRx cash) | $0.50 to $4 | 36-hour duration; also available as daily 5 mg | | HealthRX telehealth + Rx | Varies | Online evaluation + pharmacy-direct prescription |
The 20 mg sildenafil tablet strategy works because the per-tablet cost is the same regardless of strength at most pharmacies. Five 20 mg tablets equal one 100 mg dose, but the per-tablet pricing makes the total cheaper than buying a single 100 mg tablet at some outlets.
When to Talk to Your Doctor
Seek evaluation for erectile dysfunction if you experience consistent difficulty achieving or maintaining erections sufficient for satisfactory sexual activity over a period of three months or longer. The International Index of Erectile Function (IIEF-5) questionnaire, a validated five-item screening tool, can help quantify severity. A score of 21 or below (out of 25) suggests some degree of ED.
Your evaluation should include a focused history (onset, situational vs. generalized, libido, relationship factors), medication review (beta-blockers, SSRIs, and thiazide diuretics are common contributors), and basic labs: fasting glucose or HbA1c, lipid panel, total testosterone (drawn before 10 AM), and TSH if clinically indicated [9].
If your Christiana Care plan does not cover sildenafil, or if copays exceed cash-pay alternatives, a telehealth provider like HealthRX can evaluate your symptoms, prescribe appropriately, and send the prescription to a pharmacy where you have confirmed the lowest price. The entire process can be completed without an in-person office visit in most states.
Frequently asked questions
›Does Christiana Care Health System cover Viagra?
›Is generic sildenafil the same as Viagra?
›How much does generic sildenafil cost without insurance?
›Do I need prior authorization for sildenafil on Christiana Care insurance?
›What quantity limits apply to sildenafil on insurance plans?
›Can I appeal a Viagra or sildenafil coverage denial?
›Is tadalafil (generic Cialis) covered if sildenafil is not?
›Can I get a sildenafil prescription through telehealth?
›Is erectile dysfunction a sign of heart disease?
›Can I take sildenafil with blood pressure medication?
›What is the recommended starting dose of sildenafil?
›Does Christiana Care cover Viagra for pulmonary hypertension?
References
- FDA. FDA approves first generic Viagra. December 2017. https://www.fda.gov/news-events/press-announcements/fda-approves-first-generic-viagra
- Ghofrani HA, et al. Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial. Lancet. 2002;360(9337):895-900. https://pubmed.ncbi.nlm.nih.gov/12354470/
- FDA. Viagra (sildenafil citrate) prescribing information. Revised 2014. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020895s039s040lbl.pdf
- FDA. Cialis (tadalafil) prescribing information. Revised 2011. https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021368s020s021lbl.pdf
- Goldstein I, et al. Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med. 1998;338(20):1397-1404. https://pubmed.ncbi.nlm.nih.gov/9580646/
- Padma-Nathan H, et al. Efficacy and safety of sildenafil citrate in men with erectile dysfunction and stable coronary artery disease. J Am Coll Cardiol. 2002. https://pubmed.ncbi.nlm.nih.gov/9614171/
- Kloner RA, et al. Cardiovascular safety of phosphodiesterase type 5 inhibitors after nearly two decades on the market. Sex Med Rev. 2018;6(4):583-594. https://pubmed.ncbi.nlm.nih.gov/29293890/
- Nehra A, et al. The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clin Proc. 2012;87(8):766-778. https://pubmed.ncbi.nlm.nih.gov/22789088/
- Burnett AL, et al. Erectile dysfunction: AUA guideline. J Urol. 2018;200(3):633-641. https://pubmed.ncbi.nlm.nih.gov/29746858/